Acumen Pharmaceuticals ABOS
NASDAQ ABOS
$2.05 +0.03 (+1.74%)
As of: Oct 21, 2026 · 11:13 AM EDT

Acumen Pharmaceuticals (ABOS) Other Non-Current Liabilities (2023 - 2025)

Updated

Acumen Pharmaceuticals (ABOS) recorded Other Non-Current Liabilities of $39,000 in Q3 2025, down 49.4% from the prior quarter.

Analysis

Acumen Pharmaceuticals (ABOS) Other Non-Current Liabilities (2023 - 2025) Analysis & Trends

At the end of FY2024, Acumen Pharmaceuticals reported Other Non-Current Liabilities of $150,000, down 47.2% from FY2023.

  • Across earlier years, Other Non-Current Liabilities came in at $284,000 in FY2023.
  • Per Business Quant, the preceding three quarters came in at $77,000 (Q2 2025), $114,000 (Q1 2025) and $150,000 (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,129.91 Bn 1,098.50 Bn 19.71 Bn
2 Johnson & Johnson 613.69 Bn 532.22 Bn 17.26 Bn
3 AbbVie 503.05 Bn 476.16 Bn 12.70 Bn
4 Merck 367.72 Bn 322.10 Bn 12.21 Bn
5 Novartis Ag 297.87 Bn 261.86 Bn 11.24 Bn
6 Astrazeneca 261.30 Bn 234.99 Bn 12.86 Bn
7 Amgen 235.86 Bn 191.25 Bn 7.24 Bn
8 Gilead Sciences 190.51 Bn 164.71 Bn 6.22 Bn
9 Pfizer 169.83 Bn 116.48 Bn 10.94 Bn
10 Acumen Pharmaceuticals 146.31 Mn -335.76 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 39,000.00
Jun 30, 2025 77,000.00
Mar 31, 2025 114,000.00
Dec 31, 2024 150,000.00
Dec 31, 2023 284,000.00
API Access

Acumen Pharmaceuticals Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ABOS&period=max&api_key=YOUR_API_KEY